Uihlein Richard E bought GALT
July 31, 2026 · Form 4 insider transaction
Uihlein Richard E bought 2,550,932 shares of Galectin Therapeutics Inc. at $4.05 per share, a transaction worth $10.33M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,550,932
Price
$4.05
Total value
$10.33M
InsiderUihlein Richard E
RoleDirector, 10% owner
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJuly 31, 2026
Filing dateAugust 4, 2026
Shares owned after44,713,843
OwnershipIndirect
10b5-1 planNo
AmendedNo